Parkside Financial Bank & Trust
BankPosition in CRDF — Cardiff Oncology, Inc.
CIK 1455267
SAINT LOUIS, MO
Position in CRDF
as of Jun 30, 2026
· filed Sep 4, 2026
Position Value
$500
New position
Shares Held
385
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#92
of 104 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Parkside Financial Bank & Trust holds $49,351,632 across 127 Biotechnology names. CRDF ranks #116 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
1,329,158 | $47,038,901 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
5,790 | $453,182 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
759 | $377,017 | |
| 4 | TECH |
BIO-TECHNE Corp
|
3,596 | $254,056 | |
| 5 | MRNA |
Moderna, Inc.
|
1,774 | $124,233 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
167 | $104,131 | |
| 7 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
1,050 | $102,354 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
2,302 | $89,801 |
All Filings in CRDF
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $500 | 385 | Shares | Sole | 2026-09-04 | |
| No filing history on record for this holder in this stock. | ||||||